about
HCV-HIV coinfected pregnant women: data from a multicentre study in Italy.Five-year follow-up of children with perinatal HIV-1 infection receiving early highly active antiretroviral therapy.The second generation of HIV-1 vertically exposed infants: a case series from the Italian Register for paediatric HIV infectionNerve growth factor expression correlates with severity and outcome of traumatic brain injury in childrenHomocysteine lowering by folate-rich diet or pharmacological supplementations in subjects with moderate hyperhomocysteinemia.Italian consensus statement on paediatric HIV infection.Clinical Outcomes and Prognostic Factors for Spontaneous Intracerebral Hemorrhage in Pediatric ICU: A 12-Year Experience.Early versus late tracheostomy in pediatric intensive care unit: does it matter? A 6-year experience.The number of failing organs predicts non-invasive ventilation failure in children with ALI/ARDS.Increased levels of glial cell-derived neurotrophic factor in CSF of infants with SMA.Myelomeningocele in a child with intrauterine exposure to efavirenz.Double cooling for pericardial tamponade and cardiac arrest after rewarming in neonatal asphyxia.Hemangiomas and other congenital malformations in infants exposed to antiretroviral therapy in utero.Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?Sharing features of uncommon respiratory syncytial virus complications in infants.Intranasal Nerve Growth Factor administration improves cerebral functions in a child with severe traumatic brain injury: A case report.Safety and efficacy of propofol administered by paediatricians during procedural sedation in children.Successful therapeutic hypothermia for children surviving near-hanging.Patient-controlled analgesia with fentanil and midazolam in children with postoperative neurosurgical pain.NGF, DCX, and NSE upregulation correlates with severity and outcome of head trauma in children.Intraventricular nerve growth factor infusion: a possible treatment for neurological deficits following hypoxic-ischemic brain injury in infants.Nerve growth factor and doublecortin expression correlates with improved outcome in children with severe traumatic brain injury.Intraventricular nerve growth factor infusion improves cerebral blood flow and stimulates doublecortin expression in two infants with hypoxic-ischemic brain injury.Feasibility of whole body hypothermia for neonates without congenital heart defects surviving in-hospital cardiac arrest unrelated to perinatal asphyxia."No allogeneic blood transfusion" protocol for the surgical correction of craniosynostoses. II. Clinical applicationCommon occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimensRisk of Perinatal HIV Infection in Infants Born in Italy to Immigrant MothersExpression of neurotrophic factors in cerebrospinal fluid and plasma of children with viral and bacterial meningoencephalitisInterleukin 1beta and interleukin 6 relationship with paediatric head trauma severity and outcomeInterleukin-6 and nerve growth factor upregulation correlates with improved outcome in children with severe traumatic brain injuryPolyethylene glycol 4000 vs. lactulose for the treatment of neurogenic constipation in myelomeningocele children: a randomized-controlled clinical trialLung injury from "liquid ecstasy": a role for coagulation activation?Water-immersion technique during standard upper endoscopy may be useful to drive the biopsy sampling of duodenal mucosa in children with celiac diseaseAnaesthesiological and intensive care management in craniovertebral junction surgery
P50
Q31011972-EA7C4040-3AE4-4FFB-AB48-2C9143AF0B4CQ33497040-BBF0EA1E-FD0C-4F2C-ABEE-60868EAC792EQ33673661-C7E04E89-0508-45D2-B250-05CF87B47A9EQ36991843-04F931DB-C655-4D03-AF5C-EAD4C46F0EF1Q37002528-FB8D6669-3729-4C7A-BDEF-D3FBA1EFA558Q37761853-5A271AC8-ADBF-4BB5-9D59-280F4F15FC9FQ38605455-C501158D-7F03-4365-AA86-B59D90B141FAQ38867583-7CD18DA9-E349-4DCA-BB12-C3FDAE43C212Q39728999-5F78B1CC-8B3F-40A3-B8D3-6D989AE85F30Q39815281-49402D42-7069-48A1-8AD6-6CF27EAA5DEDQ43864153-E987D0D5-5D65-4CF0-BD3D-E1AB853E9D24Q44321587-6FF51B97-2312-4918-A206-8224087C9111Q44873352-0048E895-B67E-4BD5-B901-0441882BDE39Q44990021-6BF87896-A4B6-4648-B7CE-01070835A750Q45413293-5999DFC6-A097-4AC5-B492-C2B8558CEB96Q47708550-C672F8B4-55BC-4394-96E5-AD74DBB6B343Q47959661-FE960D80-C8E0-4D37-ADAE-BADEDDAFAAEDQ48064828-11957D48-9E93-44DA-8A28-B249B74C55D3Q48581990-78EBCBDA-4CF9-4A3C-8E00-50AEE20681A9Q48741529-37BECDD2-01CD-4EF3-A336-3C8D23E5086AQ48753212-8FC6315F-C472-41D7-9155-A89EE83A0F3DQ49155630-CFC88D62-B587-46F4-9588-CFC34E0A04E6Q53434370-6C2C875A-E97E-4CEB-B990-3DF075866D2AQ54261949-633B4D9F-994C-46A5-A595-49DE18FBECBFQ56379780-03126283-775F-4A89-874B-E26ABDA40950Q56880892-2BF140D0-13C6-4014-9508-A38C4EA52647Q57716632-4849C5C1-A465-47A6-98B2-3B2566BFC5EDQ80599991-570F5B21-DC4E-40D0-9AF3-CDD58D328840Q80801528-29C3382A-2D54-449C-AF1B-30DB4557C342Q80914178-6509AB19-1860-4BE2-9330-068115D7F7A3Q83149183-10DC43B7-A312-4B37-941E-B438D95A76B5Q83820283-F82B7E16-C43D-4E1C-884C-5C1D72738E6CQ84185484-D27D72C0-3486-4B58-ADDE-83ADBB108319Q86827113-088B2A4B-3835-4F14-8DD1-D042AAEF83AB
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Orazio Genovese
@ast
Orazio Genovese
@en
Orazio Genovese
@es
Orazio Genovese
@nl
type
label
Orazio Genovese
@ast
Orazio Genovese
@en
Orazio Genovese
@es
Orazio Genovese
@nl
prefLabel
Orazio Genovese
@ast
Orazio Genovese
@en
Orazio Genovese
@es
Orazio Genovese
@nl
P106
P1153
6603945539
P31
P496
0000-0002-1989-1363